Cargando…

MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non‐small‐cell Lung Cancer

Lung cancer is a serious threat to human health due to its high morbidity and mortality. microRNAs (miRNAs) are involved in the tumorigenesis and progression of lung cancer. In this study, we elucidated the role of miRNA-4507 (miR-4507) in the pathogenesis of non‐small‐cell lung cancer (NSCLC). miR-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, MengYang, Tang, ZiBo, Wang, YiJun, Ding, JiaoJiao, Guo, Ying, Zhang, Ning, Gao, TianHui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518012/ https://www.ncbi.nlm.nih.gov/pubmed/34659550 http://dx.doi.org/10.7150/jca.60724

Ejemplares similares

A direct negative feedback loop of miR-4721/FOXA1/Nanog promotes nasopharyngeal cell stem cell enrichment and metastasis
por: Zhao, Mengyang, et al.
Publicado: (2021)

Far UV study on the non-thermal activity in the narrow line galaxies NGC 4507 and NGC 5506
por: Bergeron, J, et al.
Publicado: (1981)

4507 Developing and implementing a Principal Investigator (PI) primer to improve the conduct of human research at the University of Minnesota
por: Wright, Jessica, et al.
Publicado: (2020)

Genomic landscape of TP53-mutated myeloid malignancies
por: Abel, Haley J., et al.
Publicado: (2023)

Genomic landscape of TP53-mutated myeloid malignancies
por: Abel, Haley J., et al.
Publicado: (2023)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5
por: Wu, Mengqiu, et al.
Publicado: (2023)

TP53 allele loss, mutations and expression in malignant melanoma.
por: Flørenes, V. A., et al.
Publicado: (1994)

Assessment of TP53 Mutations in Benign and Malignant Salivary Gland Neoplasms
por: Gomes, Carolina Cavaliéri, et al.
Publicado: (2012)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
por: Sun, Hao, et al.
Publicado: (2020)

Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders
por: Li, Huangkai, et al.
Publicado: (2023)

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
por: McCubrey, James A., et al.
Publicado: (2022)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
por: Li, Xuerui, et al.
Publicado: (2020)

TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells
por: Anbalagan, Selvakumar, et al.
Publicado: (2021)

TP53 isoform junction reads based analysis in malignant and normal contexts
por: Vural, Suleyman, et al.
Publicado: (2021)

TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia
por: Alkhatabi, Heba, et al.
Publicado: (2022)

Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53
por: Chen, Keli, et al.
Publicado: (2017)

CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma
por: Wang, Hui, et al.
Publicado: (2020)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients
por: Zhang, Jian, et al.
Publicado: (2022)

TP53 mediated miR‐3647‐5p prevents progression of cervical carcinoma by targeting AGR2
por: Liu, Ronghua, et al.
Publicado: (2019)

Overexpression of hsa_circ_0006470 inhibits the malignant behavior of gastric cancer cells via regulation of miR-1234/TP53I11 axis
por: Xie, Jinbi, et al.
Publicado: (2022)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

TP53 Mutations and CDKN2A Mutations/Deletions are Highly Recurrent Molecular Alterations in the Malignant Progression of Sinonasal Papillomas
por: Brown, Noah A., et al.
Publicado: (2020)

Redox-sensitive TP53INP1 SUMOylation as an oxidative stress sensor to activate TP53
por: Bonacci, Thomas, et al.
Publicado: (2014)

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
por: Yabe, Mariko, et al.
Publicado: (2021)

TP53_PROF: a machine learning model to predict impact of missense mutations in TP53
por: Ben-Cohen, Gil, et al.
Publicado: (2022)

Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues
por: Sun, Rongwei, et al.
Publicado: (2014)

Significance of TP53 mutation in bladder cancer disease progression and drug selection
por: Wu, Guang, et al.
Publicado: (2019)

The Roles of TP53 and FGFR2 in Progress Made Treating Endometrial Cancer
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2022)

miR-106b regulates the proliferation and differentiation of neural stem/progenitor cells through Tp53inp1-Tp53-Cdkn1a axis
por: Xia, Xiaohuan, et al.
Publicado: (2019)

Updates from the TP53 universe
por: Pentimalli, Francesca
Publicado: (2018)

TP53 in Biology and Treatment of Osteosarcoma
por: Synoradzki, Kamil Jozef, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i40ogjamoq3vs5kbde4318kgc5